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Editorial on the Research Topic
Metabolic Adaptation to Cell Growth and Proliferation in Normal and Pathological Conditions
Proliferating cells must adapt their metabolism to fulfill the increased requirements for energy 
demands and biosynthetic intermediates. This adaptation is particularly relevant in cancer, where 
sustained rapid proliferation combined with the harsh conditions of the tumor microenviron-
ment represent a major metabolic challenge. Noteworthy, metabolic reprogramming is now 
considered one of the hallmarks of cancer (1). However, the one size fits all rarely applies to the 
metabolic rewiring occurring in cancer cells, which ultimately depends on the combination of 
several factors such as the tumor’s origin, the specific genetic alterations and the surrounding 
microenvironment (2). In the present Research Topic, we compile a series of articles that discuss 
different metabolic adaptations that proliferating cells undergo to sustain growth and division, 
as well as the potential therapeutic window to treat certain pathologies, with a special focus on 
cancer.
One of the most common and well-described metabolic adaptations occurring in cancer cells 
is the so-called Warburg effect, which consists on high rates of glycolysis and lactate export, even 
in the presence of oxygen (3). Abdel-Haleem et al. show that this metabolic phenotype, far from 
being an exclusive feature of tumors, is a common characteristic of the proliferative state and also 
a usual metabolic adaptation when robust transient responses are required. Interestingly, when 
Otto Warburg described this phenomenon almost a century ago, he proposed that the exacerbated 
aerobic glycolysis observed in cancer cells was due to defective mitochondria. However, as Herst and 
collaborators highlight in an extensive review about the role of mitochondria in health and disease, 
these organelles are not only usually functional in cancer cells but also all the more essential to 
generate metabolic intermediates for biosynthesis, to maintain redox balance and to trigger signaling 
pathways that promote cell growth and proliferation.
Cell cycle progression, cellular division, and metabolism are intricate processes that regulate 
each other. One of the mechanisms by which proliferating cells orchestrate these phenomena 
in a timely manner is by the use of the cell cycle machinery to control metabolism (4). On this 
subject, Denechaud et al. describe how the transcription factor E2F1 couples the progression 
of cell cycle with the expression of genes involved in several metabolic pathways and show that 
dysregulation of E2F1 activity contributes to the pathophysiology of metabolic disorders such 
as obesity and type 2 diabetes. Another emerging link between metabolism and proliferation is 
the epigenetic regulation of gene expression, which is treated here in two articles. On the one 
hand, Rabhi and collaborators and collaborators discuss how, in response to the nutritional 
status, variations in the intracellular levels of certain metabolites are sensed by epigenetic 
cofactors that in turn promote changes in gene expression. On the other hand, Bogner-Strauss 
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comments on the very recent literature about the novel roles 
of the metabolite N-acetylaspartate in lipogenesis and cancer 
progression, which include, but are not limited to, epigenetic 
modulation.
In the recent years, the importance of the interactions 
between tumor cells and their surrounding microenvironment 
has become clear (5). Two reviews describe different strategies 
developed by tumors to acquire external nutrients to sustain 
biomass production. Recounvreux et al. highlight the relevance 
of macropinocytosis as a protein source for cancer cells under 
nutrient-deprived conditions, whereas Blücher et al. show how 
lipids and other molecules delivered by adipocytes fuel tumor 
growth in breast cancer, unveiling a possible link with obesity.
One of the most important aspects about the study of the meta-
bolic adaptations occurring during proliferation is the possibility 
of developing novel therapies to treat cancer. Fendt discusses in 
an opinion article the opportunities, but also the challenges, for 
metabolism-based anticancer strategies.
Overall, in the present Research Topic, we cover some of the 
different metabolic adaptations that take place during prolif-
eration and show that they ultimately depend on both internal 
and external cues (cell type, history, metabolic context, etc.). 
Importantly, understanding the specific metabolic profile of pro-
liferating cells may contribute to the identification of metabolic 
vulnerabilities in the tumors that could be exploited to increase 
the efficacy of the current treatments.
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